Document Classification

Section Type: RESULTS

Text: Treatment with dexamethasone was not associated with improved outcome for any of six outcome variables : survival to discharge (83 %, dexamethasone group ; 89 %, placebo group) ; hemodynamic stability at 48 h (33 %, dexamethasone group ; 49 %, placebo group) ; median length of hospital stay (11 days, dexamethasone group ; 11 days, placebo group) ; normal at discharge (90 %, dexamethasone group ; 75 %, placebo group) ; normal at follow-up (90 %, dexamethasone group ; 72 %, placebo group) ; and afebrile at 48 to 72 h (61 %, dexamethasone group ; 44 %, placebo group).